Repurposing Established Cyclic Adenosine Monophosphate Reducing Agents for the Prevention and Therapy of Epidermal Growth Factor Receptor Inhibitor Resistance in Non-Small Cell Lung Cancer
Translational Lung Cancer Research - Hong Kong
doi 10.21037/tlcr.2018.03.04
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2018
Authors
Publisher
AME Publishing Company